- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04458493
Does Meal Replacement With a Carbohydrates and Protein Supplement Induce Weight Loss in Overweight and/or Obese Adults?
July 28, 2020 updated by: Peter Lemon, Western University, Canada
Participants will be randomized into two groups, one group will be the control (no intervention at all) and the other will be CHO-PRO (meal replacement, Generation UCAN supplement, 400ml, 20% solution).
Prior to the start of the experiment, all participants will be asked to record their satiety ratings, appetite and desire to eat (10-point visual analogue scale) 30, 60 and 120 minutes after their regular dinner for 3 days.
On the first day of the experiment, all participants will be asked to measure their waist and hip circumferences, fasting blood glucose level, maximal number of pushups and body weight using a scale at home prior to breakfast.
Instructions on how to do the measurements properly will be recorded in a video and distributed to the participants.
Participants in the control group will not receive any intervention.
Participants in the CHO-PRO group will be provided with the supplement and they will be asked to consume the CHO - protein supplement (Generation UCAN supplement, 250ml, 10% solution) 6 to 7 hours after lunch, in place of their dinner for 6 weeks.
They will also be asked to record their satiety ratings, appetite and desire to eat (10-point visual analogue scale) 30, 60 and 120 minutes after each meal replacement drink.
All participants will be required to complete a dietary record, prior to, and during (at weeks 2 and 4) intervention.
To track adherence of the CHO-PRO group, participants will be asked to check off the calendar that they did not consume the meal replacement due to various reasons.
On day 43, all participants will be asked measure again waist and hip circumferences, fasting blood glucose level, maximal number of pushups and body weight using a scale at home prior to breakfast again.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- sedentary (<2 moderate exercise bouts/wk)
- between the ages of 18 to 40y
- body mass index (BMI) between >25
Exclusion Criteria:
- do not eat three meals a day typically
- taking medication that affects their eating patterns
- have metabolic and gastrointestinal diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: control
no supplement will be provided on the day of the experiment
|
satiety ratings, appetite and desire to eat (10-point visual analogue scale) will be measured at 30, 60 and 120 minutes after each meal replacement drink
|
|
Experimental: Generation UCAN
carbohydrates - protein (Generation UCAN supplement, 400ml, 20% solution)
|
satiety ratings, appetite and desire to eat (10-point visual analogue scale) will be measured at 30, 60 and 120 minutes after each meal replacement drink
meal replacement, Generation UCAN supplement, 400ml, 20% solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes in body weight
Time Frame: 1 day prior to the start of the experiment and on the 31st day of the experiment
|
body weight will be measured using a scale at home prior to breakfast
|
1 day prior to the start of the experiment and on the 31st day of the experiment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes in waist and hip circumferences
Time Frame: 1 day prior to the start of the experiment and on the 31st day of the experiment
|
waist and hip circumferences will be measured using a measuring tape at home prior to breakfast
|
1 day prior to the start of the experiment and on the 31st day of the experiment
|
|
changes in fasted blood glucose
Time Frame: 1 day prior to the start of the experiment and on the 31st day of the experiment
|
blood glucose will be measured through finger pricks
|
1 day prior to the start of the experiment and on the 31st day of the experiment
|
|
changes in appetite ratings
Time Frame: 30, 60 and 120 minutes after each meal replacement drink
|
appetite ratings will be asked with the use a 10 point visual analog scale (VAS), 10 being strong desire to consume food and 1 being no desire to consume food at all
|
30, 60 and 120 minutes after each meal replacement drink
|
|
changes in desire to eat ratings
Time Frame: 30, 60 and 120 minutes after each meal replacement drink
|
desire to eat ratings will be asked with the use a 10 point visual analog scale (VAS), 10 being no desire to eat at all and 1 being strong desire to eat
|
30, 60 and 120 minutes after each meal replacement drink
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2020
Primary Completion (Anticipated)
January 1, 2021
Study Completion (Anticipated)
July 1, 2021
Study Registration Dates
First Submitted
June 29, 2020
First Submitted That Met QC Criteria
July 1, 2020
First Posted (Actual)
July 7, 2020
Study Record Updates
Last Update Posted (Actual)
July 29, 2020
Last Update Submitted That Met QC Criteria
July 28, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 116302
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on satiety
-
Laval UniversityAliments ULTIMA Foods Inc.Completed
-
Federico II UniversityCompleted
-
Vora Life LLCKGK Science Inc.Not yet recruitingHealthy Adults | Hunger | Satiety | High BMICanada
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)Completed
-
Solae, LLCGlycemic Index Laboratories, IncCompleted
-
The Hillshire Brands CompanyBiofortis Clinical Research, Inc.Unknown
-
Singapore Institute of Food and Biotechnology InnovationNot yet recruitingHealthy Male Adults Participants
-
Western University, CanadaUnknown
-
University of California, San FranciscoCompletedWeight Loss | Morbid ObesityUnited States